Center-Authored Papers

Filters: Author is Crawford, Jeffrey  [Clear All Filters]
Journal Article
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ et al..  2006.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(19):3187-205. Abstract
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Lyman GH, Dale DC, Legg JC, Abella E, Morrow PK, Whittaker S, Crawford J.  2015.  Assessing patients' risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk? Cancer medicine. Abstract
Lyman GH, Crawford J, Tomita D, Whittaker S, Dale DC.  2016.  Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphoma.. Leukemia & lymphoma. 57(2):283-290. Abstract
Crawford J, Dale DC, Lyman GH.  2004.  Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.. Cancer. 100(2):228-37. Abstract
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.  2011.  Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(10):1726-32. Abstract
Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH.  2009.  Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.. Cancer. 115(22):5319-28. Abstract
Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH.  2007.  Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.. Cancer. 110(7):1611-20. Abstract
Cosler LE, Sivasubramaniam V, Agboola O, Crawford J, Dale D, Lyman GH.  2005.  Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 8(1):47-52. Abstract
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V et al..  2010.  Elafin is a biomarker of graft-versus-host disease of the skin.. Science translational medicine. 2(13):13ra2. Abstract
Culakova E, Poniewierski MS, Wolff DA, Dale DC, Crawford J, Lyman GH.  2015.  The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study.. SpringerPlus. 4:396. Abstract
Kuderer NM, Dale DC, Crawford J, Lyman GH.  2007.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(21):3158-67. Abstract
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI.  2004.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(21):4302-11. Abstract
Lyman GH, Dale DC, Crawford J.  2003.  Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(24):4524-31. Abstract
Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.  2006.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.. Cancer. 106(10):2258-66. Abstract
Crawford J, Althaus B, Armitage J, Blayney DW, Cataland S, Dale DC, Demetri GD, Foran J, Heaney ML, Htoy S et al..  2005.  Myeloid growth factors clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 3(4):540-55.
Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ et al..  2013.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(10):1266-90. Abstract
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ et al..  2011.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(8):914-32.
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Crawford J, Althaus B, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP et al..  2007.  Myeloid growth factors. Clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 5(2):188-202.
Dale DC, McCarter GC, Crawford J, Lyman GH.  2003.  Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials.. Journal of the National Comprehensive Cancer Network : JNCCN. 1(3):440-54. Abstract
Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH.  2014.  Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.. Cancer medicine. 3(2):434-44. Abstract
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J.  2005.  Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.. The journal of supportive oncology. 3(6 Suppl 4):24-5.